(OTC) derivatives, investments in debt and equity securities for the Company’s own account, bond dealing, and private repos and other investments. 2. Expenses The Company’s expenses in 2018 were Baht
expenses were 60.48 million Baht and 67.49 million Baht respectively. The expenses increased in line with the number of employees to support business expansion. The Company’s net profits were 94.55 million
by Baht 34.37 million or 7.21% from the general patients of subsidiaries. 2. Cost of hospital operations increased by Baht 41.22 million or 11.03 % due to the increasing of medical personal expenses
(29,149) (27,835) 1,314 (4.72) Gross Profit 49,306 48,521 785 1.62 Reversal of allowance for doubtful accounts 6,167 4,687 1,480 31.58 Other income 1,266 5,417 (4,151) (76.63) Profit before Expenses 56,739
million or 8.87% from the general patients of subsidiaries. 2. Cost of hospital operations increased by Baht 18.41 million or 4.44% due to the increasing of medical personal expenses and depreciation from
). Selling and administrative expenses were 10.07 million Baht and 25.68 million Baht respectively. The expenses increased in line with the number of employees to support business expansion. The Company’s net
period ended March 31, 2017 showed profit before income tax benefits (expenses) of 0.94 million Baht. When combining with income tax benefits (expenses) of 0.25 million Baht, the net profit for the period
campaign in ready to move-in projects in Q2/2020 - Selling expenses in Q2/2020 amounted 225.91 million baht compared to Selling expenses in Q2/2019 which was 219.19 million baht. Selling expenses increased
revenues were able to growth better than overall of the industry. 2. Selling and Administrative Expenses Selling and Administrative Expenses increase in accordance with sales. In Q3/2019, the company’s
fluctuation of the price of stocks listed on stock exchange of Thailand. 2. Underwriting income decreased by Baht 16.53 million due to the following factors : 1.1 Underwriting expenses increased by Baht 33.37